Advertisement

Topics

GBS/CIDP Foundation Company Profile

14:12 EDT 20th September 2018 | BioPortfolio

GBS is an inflammatory disorder of the peripheral nerves and is characterized by the rapid onset of weakness and often paralysis of the legs, arms, breathing muscles and face. GBS can develop in persons of any age. CIDP is a rare disorder of the peripheral nerves with weakness occurring over two or more months and is characterized by gradually increasing weakness of the legs and, to a lesser extent, the arms. It is caused by damage to the covering of the nerves called myelin.


News Articles [437 Associated News Articles listed on BioPortfolio]

Estelle Benson, Founder of GBS|CIDP Foundation International: Abbey S. Meyers Leadership Award Honoree

The GBS|CIDP Foundation International, one of the first member organizations of NORD, works towards a future when no one with Guillain-Barre syndrome (GBS), chronic inflammatory demyelinating pol...

[Comment] Fingolimod and CIDP: insights from negative results

Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is an immune-mediated neuropathy that is frequently responsive to treatment with intravenous immunoglobulin (IVIg) or corticosteroids, ...

Chronic Inflammatory Demyelinating Polyneuropathy CIDP Epidemiology Forecast to 2027 [Report Updated: 14022018] Prices from USD $3250

DelveInsight's "Chronic Inflammatory Demyelinating Polyneuropathy CIDP Epidemiology Forecast, 2027 report provides a comprehensive analysis of the Chronic Inflammatory Demyelinating Polyneuropathy ...

FDA, EMA approve CSL's Hizentra for CIDP

Chronic Inflammatory Demyelinating Polyneuropathy CIDP Market Insight, Epidemiology and Market Forecast 2027 [Report Updated: 14022018] Prices from USD $6250

DelveInsight's "Chronic Inflammatory Demyelinating Polyneuropathy CIDP Market Insight, Epidemiology and Market Forecast 2027" report provides a detailed analysis of the Chronic Inflammatory Demyeli...

CSL's Hizentra gains approvals for rare disease CIDP

Chronic Inflammatory Demyelinating Polyneuropathy CIDP Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2018 [Report Updated: 14022018] Prices from USD $2000

IntroductionDelveInsight's, Chronic Inflammatory Demyelinating Polyneuropathy CIDP Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2018" report provides comprehensive insights abou...

Chronic Inflammatory Demyelinating Polyneuropathy CIDP Pipeline Insight, 2018 [Report Updated: 14022018] Prices from USD $1250

"Chronic Inflammatory Demyelinating Polyneuropathy CIDP Pipeline Insight, 2018 report by DelveInsight offers comprehensive Insight of the pipeline under development therapeutics scenario and growth p...

Drugs and Medications [451 Associated Drugs and Medications listed on BioPortfolio]

Esika [Ventura Corporation (San Juan, P.R)]

ēsika 3-in-1 Pro Make Up Foundation SPF 20

Sheer cover mineral foundation [Guthy-Renker LLC]

Sheer Cover Mineral Foundation SPF-15

Cle de peau beaute silky foundation i [SHISEIDO CO., LTD.]

CPB Silky Cream Foundation I

Cle de peau beaute foundation i [SHISEIDO CO., LTD.]

cle de peau BEAUTE Cream Foundation I

Shiseido perfect refining foundation [SHISEIDO AMERICA INC.]

SHISEIDO Perfect Refining Foundation

PubMed Articles [230 Associated PubMed Articles listed on BioPortfolio]

Nerve ultrasound can distinguish chronic inflammatory demyelinating polyneuropathy from demyelinating diabetic sensorimotor polyneuropathy.

Diabetic patients with poor glycaemic control can demonstrate demyelinating distal sensorimotor polyneuropathy (D-DSP) on electrophysiology. Distinguishing D-DSP from chronic inflammatory demyelinatin...

Differences between Acute-onset Chronic Inflammatory Demyelinating Polyneuropathy (A-CIDP) and Acute Inflammatory Demyelinating Polyneuropathy (AIDP) in adult patients.

Acute Inflammatory Demyelinating Polyneuropathy (AIDP) and Acute-onset Chronic Inflammatory Demyelinating Polyneuropathy (A-CIDP) are conditions presenting overlapping clinical features during early s...

Reductions in muscle quality and quantity in CIDP patients assessed by magnetic resonance imaging.

Weakness in patients with chronic inflammatory demyelinating polyneuropathy (CIDP) may be caused by decreases in muscle quantity and quality, but these have not been explored.

The Florence Nightingale Foundation: developing nursing's leaders.

Ursula Ward, Chief Executive, Florence Nightingale Foundation, chiefexec@florence-nightingale-foundation.org.uk , describes the role of the foundation and its plans for the future.

Nerve Ultrasound Predicts Treatment Response in Chronic Inflammatory Demyelinating Polyradiculoneuropathy-a Prospective Follow-Up.

As reliable biomarkers of disease activity are lacking, monitoring of therapeutic response in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) remains a challenge. We sought to determi...

Clinical Trials [268 Associated Clinical Trials listed on BioPortfolio]

Biomark Study: Predict Intravenous Immunoglobulin Responders in Chronic Inflammatory Demyelinating Polyradiculoneuropathy

This study aims analyze the transcriptome to identify predictive biomarkers of IVIG in CIDP patients. 25 patients with a diagnosis of CIDP according to European criteria, naïve of treatme...

Panzyga in CIDP Administered at Different Infusion Rates

Chronic inflammatory demyelinating polyneuropathy (CIDP) is a treatable form of peripheral neuropathy with suspected autoimmune cause. The current first-line treatment is IVIG (immune glob...

Diffusion Tensor Imaging in Chronic Inflammatory Demyelinating Polyneuropathy (PIDC)

The main purpose of this study is to assess the clinical feasibility of diffusion tensor imaging (DTI) for the diagnosis of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)...

Long-Term Tolerability and Safety of HYQVIA/HyQvia in CIDP

The purpose of this study is to assess the long-term safety, tolerability, and immunogenicity of the subcutaneous (SC) treatment with Immune Globulin Subcutaneous (IGSC) facilitated with r...

Exploratory Study of Predictive Markers of the Therapeutic Response in Patients With Chronic Inflammatory Demyelinating Polyradiculoneuropathy Treated With Intravenous Immunoglobulin

Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) is an acquired neuropathy characterized by an inflammatory multifocal segmental demyelination. Due to the clinical heteroge...

Companies [1371 Associated Companies listed on BioPortfolio]

The GBS/CIDP Foundation International

GBS/CIDP Foundation

GBS is an inflammatory disorder of the peripheral nerves and is characterized by the rapid onset of weakness and often paralysis of the legs, arms, breathing muscles and face. GBS can develop in pers...

AVA Foundation

The AVA Foundation is a 501(c)(3) educational and research foundation dedicated to saving lives through promoting risk-free vascular access and evidence-based clinical practice. T...

COSHAR Foundation

The COSHAR Foundation is a 501( c )3 organization dedicated to "Impacting the Health of the World, One Community at a Time." The COSHAR Foundation's NHMN includes more than 14,000 churches and 220 co...

The NASCAR Foundation

The National Association for Stock Car Auto Racing, Inc., (NASCAR) launched The NASCAR Foundation in January 2006. The Foundation is a 501(c)(3) non-profit entity that embodies the compassion of the N...

More Information about "GBS/CIDP Foundation" on BioPortfolio

We have published hundreds of GBS/CIDP Foundation news stories on BioPortfolio along with dozens of GBS/CIDP Foundation Clinical Trials and PubMed Articles about GBS/CIDP Foundation for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of GBS/CIDP Foundation Companies in our database. You can also find out about relevant GBS/CIDP Foundation Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...


Corporate Database Quicklinks



Searches Linking to this Company Record